GNI Group Ltd.

2160 TSE Pharmaceuticals Pharmaceutical
TSE Growth
¥2,897.00
-1.02%
Delayed · cached 15 min
Fair Value Analysis →

Frequently asked questions

What sector does GNI Group Ltd. belong to?
GNI Group Ltd. operates in the Pharmaceuticals sector, specifically the Pharmaceutical industry, and is listed on the US markets.
What is the current share price of 2160?
As of the latest available quote, 2160 traded at ¥2,897.00. This price is delayed and cached for about 15 minutes.
What is the market capitalisation of 2160?
The market capitalisation of GNI Group Ltd. is approximately ¥151.98B.
Is GNI Group Ltd. profitable?
For its latest reported financial year, GNI Group Ltd. recorded a negative net profit margin of about -15.81% (a net loss for the latest period).
Does 2160 pay a dividend?
GNI Group Ltd. does not currently show a dividend yield in our data.
What is the return on equity (ROE) of 2160?
GNI Group Ltd. has a return on equity (ROE) of about -9.80%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of 2160?
Over the past 52 weeks, 2160 has traded between a low of ¥2,112.00 and a high of ¥3,740.00.

These answers are generated from reported financial data and live market figures, for educational and informational purposes only.

Educational data only. Not a recommendation to buy, sell or hold any security.